News
-
IP
The patent for the invention, “METHOD FOR MANUFACTURING DNA-EDITED EUKARYOTIC CELL, AND KIT USED IN METHOD,” was issued by the Japan Patent Office on 23 June, 2023.
-
Alliance
C4U and Inplanta Innovations enter into Collaborative Research and Alliance Agreement
-
Alliance
C4U Corporation has raised a total of 1.5 billion JPY (approximately $11 million at the then-effective exchange rate) for its Series B financing.
-
Information
Our researcher will give a poster presentation at the Keystone Symposia on Molecular and Cellular Biology “Precision Genome Engineering”, in Whistler, Canada, from March 19-23, 2023.
-
Alliance
C4U and Brain Research Institute, Niigata University have entered into the collaborative research agreement for a novel gene therapy utilizing CRISPR -Cas3 technology.
-
R&D
The paper “Dynamic mechanisms of CRISPR interference by Escherichia coli CRISPR-Cas3” was published in Nature Communications.
-
Alliance
C4U and Sumitomo Dainippon Pharma enter into Collaborative Research and Alliance Agreement
-
Alliance
C4U and Logomix have entered into the joint research agreement on applying CRISPR-Cas3 genome editing technology to Logomix’s Geno-WritingTM technology.
-
Alliance
C4U and the Center for iPS Cell Research and Application(CiRA), Kyoto University have conducted a joint research since January 2020 to promote the research utilizing novel genome editing technology over iPS cells.
-
R&D
The paper “CRISPR-Cas3-based diagnostics for SARS-CoV-2 and influenza virus” was published in iScience.